Browsing Tag
NASDAQ
803 posts
Scancell confirms Neuphoria reverse-merger talks as SCLP targets Nasdaq and Phase 3 funding
Scancell is discussing an all-share acquisition of Neuphoria Therapeutics that could secure a Nasdaq listing and strengthen funding options for the global Phase 3 trial of iSCIB1+.
Stratus Properties unlocked $21.7m in cash. Is STRS now closer to its liquidation payout?
Stratus Properties has converted a major grocery-anchored retail asset into $21.7 million of net cash, strengthening its balance sheet while placing greater attention on the timing and value of its remaining liquidation portfolio.
Could AI-guided TMS give NRx a sharper mental health platform story?
NRx’s HOPE Therapeutics begins Zeta-guided TMS treatments, sharpening NRXP’s precision psychiatry, clinic network and depression care strategy.
Can Payward turn the Bending Spoons IPO into tokenized equities’ breakout moment?
Payward Services is extending Bending Spoons IPO participation to eligible Kraken and xStocks users outside the United States, but BSPx will test whether tokenization can improve primary-market distribution without reproducing the exclusions and risks of traditional finance.
Lime wants a $1.66bn valuation, but its IPO is also a balance-sheet rescue
Lime’s proposed Nasdaq IPO could raise nearly $181 million and convert much of its debt into equity, but investors must decide whether global micromobility has finally become a durable business.
SK hynix targets $29.4bn Nasdaq raise as AI memory investment accelerates
SK hynix plans a historic $29.4 billion Nasdaq raise to expand AI memory capacity. Discover what the listing means for Nvidia, Micron and Samsung.
Why Sunrun and Tesla’s 16 GW plan could matter in the AI electricity crunch
Sunrun, Renew Home and Tesla’s 16 GW flexible power plan links home batteries to AI data centre demand, grid relief and RUN stock sentiment.
Infosys expands GlobalFoundries AI mandate as #INFY trades near its 52-week low
Infosys expands its GlobalFoundries AI mandate as #INFY nears a 52-week low. Discover the deal’s strategic value, risks and investor implications.
Bending Spoons seeks $19bn valuation as $1.6bn Nasdaq IPO tests acquisition model
Bending Spoons seeks a $19 billion valuation in its $1.62 billion Nasdaq IPO. Discover how acquisitions, rapid growth and heavy debt shape the BSP story.
Could Micron’s Anthropic deal prove memory is no longer the boring part of AI?
Find out how Micron’s Anthropic AI infrastructure agreement could affect MU stock, HBM demand, Claude growth and semiconductor competition today!